Preferred Label : Orlistat;

MeSH definition : A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity.;

MeSH synonym : Tetrahydrolipstatin; THLP; Tetrahydrolipastatin;

MeSH hyponym : Ro 18 0647;

MeSH CAS label : L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-;

MeSH Related Number : 96829-58-2 (Orlistat);

UNII : 95M8R751W8;

Details


Main resources

You can consult :

A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity.

http://www.cochrane.org/fr/CD007654/les-effets-long-terme-des-medicaments-amaigrissants-chez-les-personnes-presentant-une-elevation-de
2016
false
United Kingdom
France
French
meta-analysis
treatment outcome
hypertension
anti-obesity agents
overweight
appetite depressants
lactones
sibutramine
piperidines
pyrazoles
cyclobutanes
french abstract
Rimonabant
Orlistat

---
https://www.ema.europa.eu/medicines/human/EPAR/alli-previously-orlistat-gsk
2012
false
United Kingdom
French
syndication feed
anti-obesity agents
lactones
anti-obesity agents
enzyme inhibitors
lactones
capsules
administration, oral
treatment outcome
lipase
obesity
orlistat
drug evaluation
Orlistat
Orlistat

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68047259
2012
France
summary of product characteristics
package leaflet
capsules
Orlistat

---
https://www.ema.europa.eu/medicines/human/EPAR/Xenical
2012
United Kingdom
English
French
syndication feed
lactones
anti-obesity agents
obesity
treatment outcome
drug evaluation
lipase
enzyme inhibitors
orlistat
anti-obesity agents
enzyme inhibitors
drug evaluation
summary of product characteristics
package leaflet
Orlistat
Orlistat

---
http://www.cbip.be/pdf/tft/TF_OBES.pdf
2010
Belgium
French
pediatric obesity
obesity
obesity
obesity
treatment outcome
weight loss
diet, reducing
exercise
obesity
obesity
appetite depressants
anti-obesity agents
appetite depressants
anti-obesity agents
bariatric surgery
Outcome Assessment, Health Care
child
adolescent
sibutramine
lactones
cyclobutanes
piperidines
pyrazoles
practice guideline
table
Rimonabant
Orlistat

---
http://www.cbip.be/nieuws/index.cfm?welk=326
2009
Belgium
journal article
No-Observed-Adverse-Effect level
Orlistat

---
http://www.lecrat.eu/?s=Orlistat
2008
France
French
pregnancy
lipase
anti-obesity agents
enzyme inhibitors
lactones
orlistat
drug information
Orlistat

---
http://www.has-sante.fr/portail/display.jsp?id=c_443495
http://www.has-sante.fr/portail/jcms/c_443494/xenical-ct-2826
http://www.has-sante.fr/portail/jcms/c_604808/xenical-ct-2826-english
2006
France
French
English
anti-obesity agents
enzyme inhibitors
lipase
administration, oral
insurance, health, reimbursement
adult
treatment outcome
lactones
orlistat
lactones
evaluation of the transparency committee
Orlistat

---
Nous contacter.
04/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.